Variant report
Variant | esv3381036 |
---|---|
Chromosome Location | chr6:36153974-36156172 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:7)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:7 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr6:36144920..36147918-chr6:36154455..36157144,2 | K562 | blood: | |
2 | chr6:36155280..36157151-chr6:36161312..36162957,2 | MCF-7 | breast: | |
3 | chr6:36138949..36143534-chr6:36154662..36159482,4 | K562 | blood: | |
4 | chr6:36152501..36154693-chr6:36162205..36164087,2 | MCF-7 | breast: | |
5 | chr6:36153558..36155723-chr6:36560628..36562566,2 | K562 | blood: | |
6 | chr6:36149334..36155172-chr6:36162239..36167674,7 | K562 | blood: | |
7 | chr6:36154270..36157142-chr6:36158753..36161369,2 | MCF-7 | breast: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000096070 | chromatin interactions |
ENSG00000246982 | chromatin interactions |
ENSG00000112081 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs559475710 | chr6:36154038-36154039 | Active TSS Weak transcription Enhancers | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
2 | rs184891192 | chr6:36154072-36154073 | Active TSS Weak transcription Enhancers | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
3 | rs536092926 | chr6:36154095-36154096 | Active TSS Weak transcription Enhancers | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
4 | rs547846608 | chr6:36154162-36154163 | Active TSS Weak transcription Enhancers | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
5 | rs189785391 | chr6:36154175-36154176 | Active TSS Weak transcription Enhancers | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
6 | rs536602109 | chr6:36154190-36154191 | Active TSS Weak transcription Enhancers | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
7 | rs141475537 | chr6:36154216-36154217 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
8 | rs181152683 | chr6:36154228-36154229 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
9 | rs368008422 | chr6:36154233-36154234 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
10 | rs371970549 | chr6:36154241-36154242 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
11 | rs539304338 | chr6:36154325-36154326 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
12 | rs576992652 | chr6:36154386-36154387 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
13 | rs554198028 | chr6:36154516-36154517 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
14 | rs145149868 | chr6:36154603-36154604 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
15 | rs368459725 | chr6:36154662-36154663 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
16 | rs555062959 | chr6:36154692-36154693 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
17 | rs553659788 | chr6:36154711-36154712 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
18 | rs555629152 | chr6:36154779-36154780 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
19 | rs373435619 | chr6:36154786-36154787 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
20 | rs28874924 | chr6:36154827-36154828 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
21 | rs543590564 | chr6:36154840-36154841 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
22 | rs565265209 | chr6:36154866-36154867 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
23 | rs577194471 | chr6:36154872-36154873 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
24 | rs9380550 | chr6:36154878-36154879 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
25 | rs7451913 | chr6:36154895-36154896 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
26 | rs7454891 | chr6:36154896-36154897 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
27 | rs573648813 | chr6:36154899-36154900 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
28 | rs565485538 | chr6:36154901-36154902 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
29 | rs7451914 | chr6:36154905-36154906 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
30 | rs188893280 | chr6:36154915-36154916 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
31 | rs12208942 | chr6:36154938-36154939 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
32 | rs12208944 | chr6:36154948-36154949 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
33 | rs56959394 | chr6:36154975-36154976 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
34 | rs542562897 | chr6:36154984-36154985 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
35 | rs541064245 | chr6:36154985-36154986 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
36 | rs562663695 | chr6:36154988-36154989 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
37 | rs74630069 | chr6:36154996-36154997 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
38 | rs563190876 | chr6:36155027-36155028 | Enhancers Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
39 | rs4318865 | chr6:36155186-36155187 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
40 | rs190953788 | chr6:36155205-36155206 | Enhancers Weak transcription Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
41 | rs530512869 | chr6:36155218-36155219 | Enhancers Weak transcription Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
42 | rs138979856 | chr6:36155236-36155237 | Enhancers Weak transcription Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
43 | rs370057206 | chr6:36155244-36155245 | Enhancers Weak transcription Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
44 | rs534346015 | chr6:36155282-36155283 | Enhancers Weak transcription Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
45 | rs548037729 | chr6:36155363-36155364 | Enhancers Weak transcription Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
46 | rs566387425 | chr6:36155375-36155376 | Enhancers Weak transcription Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
47 | rs567857170 | chr6:36155378-36155379 | Enhancers Weak transcription Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
48 | rs371348991 | chr6:36155386-36155387 | Enhancers Weak transcription Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
49 | rs200152476 | chr6:36155407-36155408 | Enhancers Weak transcription Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
50 | rs200565089 | chr6:36155408-36155409 | Enhancers Weak transcription Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Follicular lymphoma | 20505157 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Leukemia | 21518781 | CNVD |
Cancer | 21637783 | CNVD |
Facial dysmorphism | 22105932 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 16751803 | CNVD |
Bladder cancer | 19088036 | CNVD |
Wilms tumour | 21544195 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Biliary cancer | 19435499 | CNVD |
Malaria | 21533027 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21858162 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Melanoma | 18172304 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Autism | 22495311 | CNVD |
Cancer | 16790693 | CNVD |
Cervical cancer | 21062161 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Systemic lupus erythematosus | 17503323 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Cancer | 21183584 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Gastric cancer | 17908304 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Schizophrenia | 19571808 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Neuroblastoma | 16790693 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Breast cancer | 16397240 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Systemic lupus erythematosus | 20877625 | CNVD |
Cleidocranial dysplasia | 18696259 | CNVD |
Holoprosencephaly | 21359414 | CNVD |
Liposarcoma | 21253554 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Fibroblasts | 20926602 | CNVD |
Systemic lupus erythematosus | 19279649 | CNVD |
Retinoblastoma | 16790693 | CNVD |
Acute myocardial infarction | 18032375 | CNVD |
Renal cell carcinoma | 19150565 | CNVD |
Systemic lupus erythematosus | 19591781 | CNVD |
Attention deficit hyperactivity disorder | 19287146 | CNVD |
Autism | 19287146 | CNVD |
Erythema nodosum in leprosy | 19287146 | CNVD |
Henoch-schoenlein purpura | 19287146 | CNVD |
Liver cirrhosis | 19287146 | CNVD |
Systemic lupus erythematosus | 19287146 | CNVD |
Autoimmune disease | 19135723 | CNVD |
Congenital adrenal hyperplasia | 18478071 | CNVD |
Systemic lupus erythematosus | 19287147 | CNVD |
Osteosarcoma | 16790693 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Cancer | 22183965 | CNVD |
Melanoma | 22183965 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Lung cancer | 18438408 | CNVD |
Glioblastoma multiforme | 21138945 | CNVD |
Breast cancer | 21364760 | CNVD |
Basal cell lymphoma | 19029149 | CNVD |
Diffuse large b-cell lymphoma | 19029149 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Chronic lymphocytic leukemia | 22228453 | CNVD |
Lung cancer | 19153074 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:36146000-36154000 | Weak transcription | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
2 | chr6:36146000-36163400 | Weak transcription | Skeletal Muscle Male | skeletal muscle |
3 | chr6:36147400-36155400 | Weak transcription | Primary T cells from cord blood | blood |
4 | chr6:36149000-36163600 | Weak transcription | Skeletal Muscle Female | skeletal muscle |
5 | chr6:36152600-36163600 | Weak transcription | Brain Angular Gyrus | brain |
6 | chr6:36153200-36155200 | Weak transcription | Primary neutrophils fromperipheralblood | blood |
7 | chr6:36153400-36155400 | Weak transcription | Primary hematopoietic stem cells | blood |
8 | chr6:36153600-36154200 | Enhancers | Lung | lung |
9 | chr6:36154000-36154200 | Active TSS | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
10 | chr6:36155000-36155200 | Enhancers | Monocytes-CD14+_RO01746 | blood |
11 | chr6:36155000-36155600 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
12 | chr6:36155000-36156200 | Enhancers | Primary monocytes fromperipheralblood | blood |
13 | chr6:36155200-36155600 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
14 | chr6:36155200-36155600 | Enhancers | HUVEC | blood vessel |
15 | chr6:36155200-36155600 | Flanking Active TSS | Monocytes-CD14+_RO01746 | blood |
16 | chr6:36155200-36155800 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
17 | chr6:36155200-36156000 | Enhancers | Primary neutrophils fromperipheralblood | blood |
18 | chr6:36155400-36155600 | Enhancers | Primary T cells from cord blood | blood |
19 | chr6:36155400-36155600 | Enhancers | Primary hematopoietic stem cells | blood |
20 | chr6:36155600-36156200 | Enhancers | Monocytes-CD14+_RO01746 | blood |
21 | chr6:36155600-36163400 | Weak transcription | Primary T cells from cord blood | blood |
22 | chr6:36155600-36163400 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
23 | chr6:36155800-36163600 | Weak transcription | Psoas Muscle | Psoas |
24 | chr6:36156000-36157600 | Weak transcription | Primary neutrophils fromperipheralblood | blood |
25 | chr6:36156000-36163400 | Weak transcription | Fetal Intestine Small | intestine |